Major changes and list of where changes have been made.
• Addition of MenB (Bexsero to routine Schedule) and changes to MenB eligibility
• inﬂuenza programme 2023
• change to mRNA-CV (grey capped, no dilution 30 µg and 15/15µg)
• Throughout changed COVID-19 ‘booster’ dose to ‘ﬁrst booster’ and ‘additional dose(s)’
• COVID-19 vaccination changed to 6 months after SARS-CoV-2 infection and previous dose for additional doses.
Full list of changes and where they occur is provided in the factsheet.